Literature DB >> 6190031

Choroidal neovascularization in long-standing case of Vogt-Koyanagi-Harada disease.

H Inomata, M Minei, Y Taniguchi, F Nishimura.   

Abstract

The eyes in a case of Vogt-Koyanagi-Harada disease (VKH) with long-standing uveitis for 26 years after the onset were studied histopathologically. It was found that typical granulomatous inflammation was persistent in the uveal tract and the choroidal neovascularization occurred in the peripheral fundus accompanied by proliferation of the retinal pigment epithelial cells (RPE). Some of the new vessels under the pigment epithelium extended into the vitreous. It was concluded that the ocular inflammation of VKH was essentially granulomatous even in this long-standing case. Disappearance of choroidal melanocytes, existence of epithelioid cells containing pigment granules, and accumulation of lymphocytes and plasma cells in the lesion indicated that the inflammation was an autoimmune reaction against uveal melanocytes, although the trigger initiating the disease remains unknown. It was further concluded that the peripheral fundus as well as the peripapillary and macular areas was a predilected site for choroidal neovascularization in chronic uveitis. The choroidal neovascularization may develop in such a way that the uveal inflammation damages the Bruch's membrane and choriocapillaris and consequently causes retinal ischemia, thus stimulating the endothelium of the choriocapillaris and the overlying RPE to proliferate. There is a close relation between choroidal neovascularization and proliferation of RPE. Choroidal neovascularization may cause reactive proliferation of the RPE and vice versa.

Entities:  

Mesh:

Year:  1983        PMID: 6190031

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

1.  Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.

Authors:  Kei Nakai; Fumi Gomi; Yasushi Ikuno; Yoshiaki Yasuno; Takeyoshi Nouchi; Nobuyuki Ohguro; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-13       Impact factor: 3.117

2.  Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.

Authors:  Daniel V Vasconcelos-Santos; Elliott H Sohn; Srinivas Sadda; Narsing A Rao
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

3.  Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome.

Authors:  Lihteh Wu; Teodoro Evans; Mario Saravia; Ariel Schlaen; Cristobal Couto
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

4.  Choroidal thickness in retinal pigment epithelial tear as measured by spectral domain optical coherence tomography.

Authors:  Kavita V Bhavsar; Lauren Branchini; Heeral Shah; Caio V Regatieri; Jay S Duker
Journal:  Retina       Date:  2014-01       Impact factor: 4.256

5.  Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Authors:  Shengping Hou; Peizeng Yang; Liping Du; Hongyan Zhou; Xiaomin Lin; Xiaoli Liu; Aize Kijlstra
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.